Company Email Format Management

Immunitas Therapeutics

Biotechnology Research Waltham, Massachusetts, United States 30 employees

Employees: 30
Contacts: 4
Emails: 4
Phones: 1

immunitastx.com LinkedIn Crunchbase

Immunitas Therapeutics Overview

Headquarters: Waltham, Massachusetts, United States
Website: immunitastx.com
Industry: Biotechnology Research
Employees: 30
Founded: 2019
Funding: 58.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Immunitas Therapeutics

Immunitas is committed to discovering and developing novel, differentiated therapeutics for patients with cancer and autoimmune diseases. Our lead program, IMT-009, targets CD161 and is in clinical trials for patients with refractory tumors across a variety of indications including MSS Colorectal Cancer, Head and Neck Cancer, and Non-Small Cell Lung Cancer. Our second program is a novel therapeutic for the treatment of autoimmune disease that builds on our specialized foundational knowledge of the CD161-CLEC2D pathway.

Immunitas Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Immunitas Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Amanda Wagner	CEO at Immunitas Therapeutics	Cambridge, Massachusetts, United States	Email Phone
Fabio Pucci	Biotech Investor at Leaps by Bayer	Boston, Massachusetts, United States	Email
Lynette Herscha		Waltham, Massachusetts, United States	Email
Diane Stebbins	Director, Clinical Operations at Immunitas Therapeutics	United States	Email